ID   PNPT1_HUMAN             Reviewed;         783 AA.
AC   Q8TCS8; Q53SU0; Q68CN1; Q7Z7D1; Q8IWX1; Q96T05; Q9BRU3; Q9BVX0;
DT   10-MAY-2005, integrated into UniProtKB/Swiss-Prot.
DT   03-OCT-2006, sequence version 2.
DT   15-MAR-2017, entry version 143.
DE   RecName: Full=Polyribonucleotide nucleotidyltransferase 1, mitochondrial;
DE            EC=2.7.7.8;
DE   AltName: Full=3'-5' RNA exonuclease OLD35;
DE   AltName: Full=PNPase old-35;
DE   AltName: Full=Polynucleotide phosphorylase 1;
DE            Short=PNPase 1;
DE   AltName: Full=Polynucleotide phosphorylase-like protein;
DE   Flags: Precursor;
GN   Name=PNPT1; Synonyms=PNPASE;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT VAL-121.
RC   TISSUE=Teratocarcinoma;
RX   PubMed=12419256; DOI=10.1016/S0022-2836(02)00947-6;
RA   Raijmakers R., Vree Egberts W., van Venrooij W.J., Pruijn G.J.M.;
RT   "Protein-protein interactions between human exosome components support
RT   the assembly of RNase PH-type subunits into a six-membered PNPase-like
RT   ring.";
RL   J. Mol. Biol. 323:653-663(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], VARIANT VAL-121, FUNCTION, AND INDUCTION.
RC   TISSUE=Melanoma;
RX   PubMed=12473748; DOI=10.1073/pnas.252643699;
RA   Leszczyniecka M., Kang D.-C., Sarkar D., Su Z.-Z., Holmes M.,
RA   Valerie K., Fisher P.B.;
RT   "Identification and cloning of human polynucleotide phosphorylase,
RT   hPNPase (old-35), in the context of terminal differentiation and
RT   cellular senescence.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:16636-16641(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT VAL-121.
RC   TISSUE=Cervix, Skin, and Urinary bladder;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 509-783.
RA   Takahashi H., Furukawa T., Yano T., Takizawa J., Abe T., Narita M.,
RA   Fuse I., Koyama S., Takahashi M., Aizawa Y.;
RT   "Immunogenic antigens eliciting humoral immune response identified in
RT   leukemia cells by SEREX method.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 538-783.
RC   TISSUE=Melanoma;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [7]
RP   FUNCTION.
RX   PubMed=12721301; DOI=10.1074/jbc.M302421200;
RA   Sarkar D., Leszczyniecka M., Kang D.C., Lebedeva I.V., Valerie K.,
RA   Dhar S., Pandita T.K., Fisher P.B.;
RT   "Down-regulation of Myc as a potential target for growth arrest
RT   induced by human polynucleotide phosphorylase (hPNPaseold-35) in human
RT   melanoma cells.";
RL   J. Biol. Chem. 278:24542-24551(2003).
RN   [8]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=12798676; DOI=10.1016/S0022-2836(03)00528-X;
RA   Piwowarski J., Grzechnik P., Dziembowski A., Dmochowska A.,
RA   Minczuk M., Stepien P.P.;
RT   "Human polynucleotide phosphorylase, hPNPase, is localized in
RT   mitochondria.";
RL   J. Mol. Biol. 329:853-857(2003).
RN   [9]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=16055741; DOI=10.1128/MCB.25.16.7333-7343.2005;
RA   Sarkar D., Park E.S., Emdad L., Randolph A., Valerie K., Fisher P.B.;
RT   "Defining the domains of human polynucleotide phosphorylase
RT   (hPNPaseOLD-35) mediating cellular senescence.";
RL   Mol. Cell. Biol. 25:7333-7343(2005).
RN   [10]
RP   FUNCTION, AND INDUCTION.
RX   PubMed=16410805; DOI=10.1038/sj.cdd.4401829;
RA   Sarkar D., Park E.S., Fisher P.B.;
RT   "Defining the mechanism by which IFN-beta dowregulates c-myc
RT   expression in human melanoma cells: pivotal role for human
RT   polynucleotide phosphorylase (hPNPaseold-35).";
RL   Cell Death Differ. 13:1541-1553(2006).
RN   [11]
RP   SUBCELLULAR LOCATION, AND INDUCTION.
RX   PubMed=16966381; DOI=10.1128/MCB.01002-06;
RA   Chen H.W., Rainey R.N., Balatoni C.E., Dawson D.W., Troke J.J.,
RA   Wasiak S., Hong J.S., McBride H.M., Koehler C.M., Teitell M.A.,
RA   French S.W.;
RT   "Mammalian polynucleotide phosphorylase is an intermembrane space
RT   RNase that maintains mitochondrial homeostasis.";
RL   Mol. Cell. Biol. 26:8475-8487(2006).
RN   [12]
RP   FUNCTION, INTERACTION WITH TCL1A, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=16934922; DOI=10.1016/j.canlet.2006.07.006;
RA   French S.W., Dawson D.W., Chen H.-W., Rainey R.N., Sievers S.A.,
RA   Balatoni C.E., Wong L., Troke J.J., Nguyen M.T.N., Koehler C.M.,
RA   Teitell M.A.;
RT   "The TCL1 oncoprotein binds the RNase PH domains of the PNPase
RT   exoribonuclease without affecting its RNA degrading activity.";
RL   Cancer Lett. 248:198-210(2007).
RN   [13]
RP   FUNCTION.
RX   PubMed=18501193; DOI=10.1016/j.bbrc.2008.05.058;
RA   Wu J., Li Z.;
RT   "Human polynucleotide phosphorylase reduces oxidative RNA damage and
RT   protects HeLa cell against oxidative stress.";
RL   Biochem. Biophys. Res. Commun. 372:288-292(2008).
RN   [14]
RP   FUNCTION, AND RNA-BINDING.
RX   PubMed=18083836; DOI=10.1261/rna.698108;
RA   Portnoy V., Palnizky G., Yehudai-Resheff S., Glaser F., Schuster G.;
RT   "Analysis of the human polynucleotide phosphorylase (PNPase) reveals
RT   differences in RNA binding and response to phosphate compared to its
RT   bacterial and chloroplast counterparts.";
RL   RNA 14:297-309(2008).
RN   [15]
RP   FUNCTION.
RX   PubMed=18083837; DOI=10.1261/rna.697308;
RA   Slomovic S., Schuster G.;
RT   "Stable PNPase RNAi silencing: its effect on the processing and
RT   adenylation of human mitochondrial RNA.";
RL   RNA 14:310-323(2008).
RN   [16]
RP   FUNCTION, IDENTIFICATION IN THE MITOCHONDRIAL DEGRADOSOME COMPLEX, AND
RP   HOMOTRIMERIZATION.
RX   PubMed=19509288; DOI=10.1074/jbc.M109.009605;
RA   Wang D.D., Shu Z., Lieser S.A., Chen P.L., Lee W.H.;
RT   "Human mitochondrial SUV3 and polynucleotide phosphorylase form a 330-
RT   kDa heteropentamer to cooperatively degrade double-stranded RNA with a
RT   3'-to-5' directionality.";
RL   J. Biol. Chem. 284:20812-20821(2009).
RN   [17]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-264; LYS-285 AND LYS-289,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [18]
RP   FUNCTION, HOMOTRIMERIZATION, HOMOOLIGOMERIZATION, AND MUTAGENESIS OF
RP   ASP-135; 445-ARG-ARG-446; SER-484 AND ASP-544.
RX   PubMed=20691904; DOI=10.1016/j.cell.2010.06.035;
RA   Wang G., Chen H.W., Oktay Y., Zhang J., Allen E.L., Smith G.M.,
RA   Fan K.C., Hong J.S., French S.W., McCaffery J.M., Lightowlers R.N.,
RA   Morse H.C. III, Koehler C.M., Teitell M.A.;
RT   "PNPASE regulates RNA import into mitochondria.";
RL   Cell 142:456-467(2010).
RN   [19]
RP   FUNCTION.
RX   PubMed=20547861; DOI=10.1073/pnas.0914143107;
RA   Das S.K., Sokhi U.K., Bhutia S.K., Azab B., Su Z.Z., Sarkar D.,
RA   Fisher P.B.;
RT   "Human polynucleotide phosphorylase selectively and preferentially
RT   degrades microRNA-221 in human melanoma cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:11948-11953(2010).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-782, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-754, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [23]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [24]
RP   VARIANT COXPD13 ARG-387, AND CHARACTERIZATION OF VARIANT COXPD13
RP   ARG-387.
RX   PubMed=23084291; DOI=10.1016/j.ajhg.2012.09.001;
RA   Vedrenne V., Gowher A., De Lonlay P., Nitschke P., Serre V.,
RA   Boddaert N., Altuzarra C., Mager-Heckel A.M., Chretien F., Entelis N.,
RA   Munnich A., Tarassov I., Rotig A.;
RT   "Mutation in PNPT1, which encodes a polyribonucleotide
RT   nucleotidyltransferase, impairs RNA import into mitochondria and
RT   causes respiratory-chain deficiency.";
RL   Am. J. Hum. Genet. 91:912-918(2012).
RN   [25]
RP   VARIANT DFNB70 GLY-475, AND CHARACTERIZATION OF VARIANT DFNB70
RP   GLY-475.
RX   PubMed=23084290; DOI=10.1016/j.ajhg.2012.09.002;
RA   von Ameln S., Wang G., Boulouiz R., Rutherford M.A., Smith G.M.,
RA   Li Y., Pogoda H.M., Nurnberg G., Stiller B., Volk A.E., Borck G.,
RA   Hong J.S., Goodyear R.J., Abidi O., Nurnberg P., Hofmann K.,
RA   Richardson G.P., Hammerschmidt M., Moser T., Wollnik B., Koehler C.M.,
RA   Teitell M.A., Barakat A., Kubisch C.;
RT   "A mutation in PNPT1, encoding mitochondrial-RNA-import protein
RT   PNPase, causes hereditary hearing loss.";
RL   Am. J. Hum. Genet. 91:919-927(2012).
CC   -!- FUNCTION: RNA-binding protein implicated in numerous RNA metabolic
CC       processes. Catalyzes the phosphorolysis of single-stranded
CC       polyribonucleotides processively in the 3'-to-5' direction.
CC       Mitochondrial intermembrane factor with RNA-processing
CC       exoribonulease activity. Component of the mitochondrial
CC       degradosome (mtEXO) complex, that degrades 3' overhang double-
CC       stranded RNA with a 3'-to-5' directionality in an ATP-dependent
CC       manner. Required for correct processing and polyadenylation of
CC       mitochondrial mRNAs. Plays a role as a cytoplasmic RNA import
CC       factor that mediates the translocation of small RNA components,
CC       like the 5S RNA, the RNA subunit of ribonuclease P and the
CC       mitochondrial RNA-processing (MRP) RNA, into the mitochondrial
CC       matrix. Plays a role in mitochondrial morphogenesis and
CC       respiration; regulates the expression of the electron transport
CC       chain (ETC) components at the mRNA and protein levels. In the
CC       cytoplasm, shows a 3'-to-5' exoribonuclease mediating mRNA
CC       degradation activity; degrades c-myc mRNA upon treatment with
CC       IFNB1/IFN-beta, resulting in a growth arrest in melanoma cells.
CC       Regulates the stability of specific mature miRNAs in melanoma
CC       cells; specifically and selectively degrades miR-221,
CC       preferentially. Plays also a role in RNA cell surveillance by
CC       cleaning up oxidized RNAs. Binds to the RNA subunit of
CC       ribonuclease P, MRP RNA and miR-221 microRNA.
CC       {ECO:0000269|PubMed:12473748, ECO:0000269|PubMed:12721301,
CC       ECO:0000269|PubMed:12798676, ECO:0000269|PubMed:16055741,
CC       ECO:0000269|PubMed:16410805, ECO:0000269|PubMed:16934922,
CC       ECO:0000269|PubMed:18083836, ECO:0000269|PubMed:18083837,
CC       ECO:0000269|PubMed:18501193, ECO:0000269|PubMed:19509288,
CC       ECO:0000269|PubMed:20547861, ECO:0000269|PubMed:20691904}.
CC   -!- CATALYTIC ACTIVITY: RNA(n+1) + phosphate = RNA(n) + a nucleoside
CC       diphosphate.
CC   -!- SUBUNIT: Homotrimer; in free form. Homooligomer. Component of the
CC       mitochondrial degradosome (mtEXO) complex which is a
CC       heteropentamer containing 2 copies of SUPV3L1 and 3 copies of
CC       PNPT1. Interacts with TCL1A; the interaction has no effect on
CC       PNPT1 exonuclease activity. {ECO:0000269|PubMed:16934922,
CC       ECO:0000269|PubMed:19509288}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Mitochondrion. Mitochondrion
CC       intermembrane space; Peripheral membrane protein.
CC   -!- INDUCTION: Up-regulated in cells upon senescence and terminal
CC       differentiation. Up-regulated after treatment with IFNB1/IFN-beta.
CC       {ECO:0000269|PubMed:12473748, ECO:0000269|PubMed:16410805,
CC       ECO:0000269|PubMed:16966381}.
CC   -!- DISEASE: Combined oxidative phosphorylation deficiency 13
CC       (COXPD13) [MIM:614932]: A mitochondrial disorder characterized by
CC       early onset severe encephalomyopathy, dystonia, choreoathetosis,
CC       bucofacial dyskinesias and combined mitochondrial respiratory
CC       chain deficiency. Nerve conductions velocities are decreased.
CC       Levels of plasma and cerebrospinal fluid lactate are increased.
CC       {ECO:0000269|PubMed:23084291}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Deafness, autosomal recessive, 70 (DFNB70) [MIM:614934]:
CC       A form of non-syndromic deafness characterized by severe,
CC       bilateral hearing impairment with prelingual onset, resulting in
CC       inability to acquire normal speech. {ECO:0000269|PubMed:23084290}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the polyribonucleotide
CC       nucleotidyltransferase family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ458465; CAD30289.1; -; mRNA.
DR   EMBL; AY027528; AAK13047.1; -; mRNA.
DR   EMBL; AC015982; AAY24271.1; -; Genomic_DNA.
DR   EMBL; BC000862; AAH00862.2; -; mRNA.
DR   EMBL; BC005986; AAH05986.1; -; mRNA.
DR   EMBL; BC053660; AAH53660.1; -; mRNA.
DR   EMBL; AY290863; AAP44472.1; -; mRNA.
DR   EMBL; CR749867; CAH18709.1; -; mRNA.
DR   CCDS; CCDS1856.1; -.
DR   PIR; T50626; T50626.
DR   RefSeq; NP_149100.2; NM_033109.4.
DR   UniGene; Hs.388733; -.
DR   PDB; 3U1K; X-ray; 2.13 A; A/B/C/D=46-669.
DR   PDBsum; 3U1K; -.
DR   ProteinModelPortal; Q8TCS8; -.
DR   SMR; Q8TCS8; -.
DR   BioGrid; 124579; 32.
DR   IntAct; Q8TCS8; 5.
DR   MINT; MINT-3058521; -.
DR   STRING; 9606.ENSP00000393953; -.
DR   iPTMnet; Q8TCS8; -.
DR   PhosphoSitePlus; Q8TCS8; -.
DR   SwissPalm; Q8TCS8; -.
DR   DMDM; 115502437; -.
DR   REPRODUCTION-2DPAGE; IPI00291165; -.
DR   EPD; Q8TCS8; -.
DR   MaxQB; Q8TCS8; -.
DR   PaxDb; Q8TCS8; -.
DR   PeptideAtlas; Q8TCS8; -.
DR   PRIDE; Q8TCS8; -.
DR   Ensembl; ENST00000415374; ENSP00000393953; ENSG00000138035.
DR   Ensembl; ENST00000447944; ENSP00000400646; ENSG00000138035.
DR   GeneID; 87178; -.
DR   KEGG; hsa:87178; -.
DR   UCSC; uc002rzf.4; human.
DR   CTD; 87178; -.
DR   DisGeNET; 87178; -.
DR   GeneCards; PNPT1; -.
DR   H-InvDB; HIX0023979; -.
DR   HGNC; HGNC:23166; PNPT1.
DR   HPA; CAB033424; -.
DR   HPA; HPA034602; -.
DR   HPA; HPA034603; -.
DR   MalaCards; PNPT1; -.
DR   MIM; 610316; gene.
DR   MIM; 614932; phenotype.
DR   MIM; 614934; phenotype.
DR   neXtProt; NX_Q8TCS8; -.
DR   OpenTargets; ENSG00000138035; -.
DR   Orphanet; 90636; Autosomal recessive non-syndromic sensorineural deafness type DFNB.
DR   Orphanet; 319514; Combined oxidative phosphorylation defect type 13.
DR   PharmGKB; PA134915354; -.
DR   eggNOG; KOG1067; Eukaryota.
DR   eggNOG; COG1185; LUCA.
DR   GeneTree; ENSGT00390000014001; -.
DR   HOVERGEN; HBG053625; -.
DR   InParanoid; Q8TCS8; -.
DR   KO; K00962; -.
DR   OMA; RFMFHYN; -.
DR   OrthoDB; EOG091G03MA; -.
DR   PhylomeDB; Q8TCS8; -.
DR   TreeFam; TF315264; -.
DR   BRENDA; 2.7.7.8; 2681.
DR   ChiTaRS; PNPT1; human.
DR   GenomeRNAi; 87178; -.
DR   PRO; PR:Q8TCS8; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000138035; -.
DR   CleanEx; HS_PNPT1; -.
DR   ExpressionAtlas; Q8TCS8; baseline and differential.
DR   Genevisible; Q8TCS8; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:Ensembl.
DR   GO; GO:0045025; C:mitochondrial degradosome; IDA:UniProtKB.
DR   GO; GO:0005758; C:mitochondrial intermembrane space; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IEA:Ensembl.
DR   GO; GO:0042788; C:polysomal ribosome; IEA:Ensembl.
DR   GO; GO:0000175; F:3'-5'-exoribonuclease activity; IDA:UniProtKB.
DR   GO; GO:0035198; F:miRNA binding; IDA:UniProtKB.
DR   GO; GO:0034046; F:poly(G) binding; IDA:UniProtKB.
DR   GO; GO:0008266; F:poly(U) RNA binding; IDA:UniProtKB.
DR   GO; GO:0004654; F:polyribonucleotide nucleotidyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; IDA:UniProtKB.
DR   GO; GO:0035458; P:cellular response to interferon-beta; IDA:UniProtKB.
DR   GO; GO:0034599; P:cellular response to oxidative stress; IDA:UniProtKB.
DR   GO; GO:0097421; P:liver regeneration; IEA:Ensembl.
DR   GO; GO:0000958; P:mitochondrial mRNA catabolic process; IDA:UniProtKB.
DR   GO; GO:0097222; P:mitochondrial mRNA polyadenylation; IMP:UniProtKB.
DR   GO; GO:0000965; P:mitochondrial RNA 3'-end processing; IMP:UniProtKB.
DR   GO; GO:0000964; P:mitochondrial RNA 5'-end processing; IMP:UniProtKB.
DR   GO; GO:0000957; P:mitochondrial RNA catabolic process; IDA:UniProtKB.
DR   GO; GO:0070584; P:mitochondrion morphogenesis; ISS:UniProtKB.
DR   GO; GO:0071850; P:mitotic cell cycle arrest; IDA:UniProtKB.
DR   GO; GO:0006402; P:mRNA catabolic process; IDA:UniProtKB.
DR   GO; GO:0045926; P:negative regulation of growth; IDA:UniProtKB.
DR   GO; GO:0071042; P:nuclear polyadenylation-dependent mRNA catabolic process; IDA:UniProtKB.
DR   GO; GO:2000627; P:positive regulation of miRNA catabolic process; IDA:UniProtKB.
DR   GO; GO:0000962; P:positive regulation of mitochondrial RNA catabolic process; IDA:UniProtKB.
DR   GO; GO:0061014; P:positive regulation of mRNA catabolic process; IMP:UniProtKB.
DR   GO; GO:0051260; P:protein homooligomerization; IDA:UniProtKB.
DR   GO; GO:0070207; P:protein homotrimerization; IDA:UniProtKB.
DR   GO; GO:0043457; P:regulation of cellular respiration; ISS:UniProtKB.
DR   GO; GO:2000772; P:regulation of cellular senescence; IDA:UniProtKB.
DR   GO; GO:0051591; P:response to cAMP; IEA:Ensembl.
DR   GO; GO:0060416; P:response to growth hormone; IEA:Ensembl.
DR   GO; GO:0006401; P:RNA catabolic process; IDA:UniProtKB.
DR   GO; GO:0035927; P:RNA import into mitochondrion; IDA:UniProtKB.
DR   GO; GO:0043631; P:RNA polyadenylation; IDA:UniProtKB.
DR   GO; GO:0035928; P:rRNA import into mitochondrion; IDA:UniProtKB.
DR   Gene3D; 1.10.10.400; -; 1.
DR   Gene3D; 3.30.1370.10; -; 1.
DR   Gene3D; 3.30.230.70; -; 2.
DR   InterPro; IPR001247; ExoRNase_PH_dom1.
DR   InterPro; IPR015847; ExoRNase_PH_dom2.
DR   InterPro; IPR004087; KH_dom.
DR   InterPro; IPR004088; KH_dom_type_1.
DR   InterPro; IPR012340; NA-bd_OB-fold.
DR   InterPro; IPR012162; PNPase.
DR   InterPro; IPR027408; PNPase/RNase_PH_dom.
DR   InterPro; IPR015848; PNPase_PH_RNA-bd_bac/org-type.
DR   InterPro; IPR020568; Ribosomal_S5_D2-typ_fold.
DR   InterPro; IPR022967; S1_dom.
DR   InterPro; IPR003029; S1_domain.
DR   PANTHER; PTHR11252; PTHR11252; 1.
DR   Pfam; PF00013; KH_1; 1.
DR   Pfam; PF03726; PNPase; 1.
DR   Pfam; PF01138; RNase_PH; 2.
DR   Pfam; PF03725; RNase_PH_C; 1.
DR   Pfam; PF00575; S1; 1.
DR   PIRSF; PIRSF005499; PNPase; 1.
DR   SMART; SM00322; KH; 1.
DR   SMART; SM00316; S1; 1.
DR   SUPFAM; SSF46915; SSF46915; 1.
DR   SUPFAM; SSF50249; SSF50249; 1.
DR   SUPFAM; SSF54211; SSF54211; 2.
DR   SUPFAM; SSF54791; SSF54791; 1.
DR   SUPFAM; SSF55666; SSF55666; 2.
DR   TIGRFAMs; TIGR03591; polynuc_phos; 1.
DR   PROSITE; PS50084; KH_TYPE_1; 1.
DR   PROSITE; PS50126; S1; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome; Cytoplasm; Deafness;
KW   Disease mutation; Exonuclease; Hydrolase; Membrane; Mitochondrion;
KW   mRNA processing; Non-syndromic deafness; Nuclease;
KW   Nucleotidyltransferase; Phosphoprotein; Polymorphism;
KW   Reference proteome; RNA-binding; Transferase; Transit peptide;
KW   Transport.
FT   TRANSIT       1     45       Mitochondrion. {ECO:0000255}.
FT   CHAIN        46    783       Polyribonucleotide nucleotidyltransferase
FT                                1, mitochondrial.
FT                                /FTId=PRO_0000024751.
FT   DOMAIN      605    664       KH. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00117}.
FT   DOMAIN      679    750       S1 motif. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00180}.
FT   MOD_RES     250    250       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q8K1R3}.
FT   MOD_RES     264    264       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     285    285       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     289    289       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     552    552       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q8K1R3}.
FT   MOD_RES     754    754       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     782    782       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   VARIANT     121    121       I -> V (in dbSNP:rs782572).
FT                                {ECO:0000269|PubMed:12419256,
FT                                ECO:0000269|PubMed:12473748,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_027787.
FT   VARIANT     230    230       E -> Q (in dbSNP:rs34928857).
FT                                /FTId=VAR_050610.
FT   VARIANT     387    387       Q -> R (in COXPD13; the mutation alters
FT                                multimerization of the protein;
FT                                dbSNP:rs397514598).
FT                                {ECO:0000269|PubMed:23084291}.
FT                                /FTId=VAR_069248.
FT   VARIANT     475    475       E -> G (in DFNB70; results in a
FT                                hypofunctional protein leading to
FT                                disturbed enzyme trimerization and
FT                                impaired mitochondrial RNA import;
FT                                dbSNP:rs397514599).
FT                                {ECO:0000269|PubMed:23084290}.
FT                                /FTId=VAR_069249.
FT   VARIANT     590    590       N -> D (in dbSNP:rs7594497).
FT                                /FTId=VAR_027788.
FT   MUTAGEN     135    135       D->G: Inhibits poly(A) polymerase and RNA
FT                                degradation activities. Inhibits the
FT                                import or stabilization of RNase P RNA
FT                                into the mitochondrial matrix. Does not
FT                                inhibit homotrimerization activity.
FT                                {ECO:0000269|PubMed:20691904}.
FT   MUTAGEN     445    446       RR->EE: Stimulates in vitro poly(A)
FT                                polymerase activity. Inhibits RNA
FT                                degradation activity. Does not inhibit
FT                                the import or stabilization of RNase P
FT                                RNA into the mitochondrial matrix. Does
FT                                not inhibit homotrimerization activity.
FT                                {ECO:0000269|PubMed:20691904}.
FT   MUTAGEN     484    484       S->A: Inhibits poly(A) polymerase and RNA
FT                                degradation activities. Does not inhibit
FT                                the import or stabilization of RNase P
FT                                RNA into the mitochondrial matrix. Does
FT                                not inhibit homotrimerization activity.
FT                                {ECO:0000269|PubMed:20691904}.
FT   MUTAGEN     544    544       D->A: Stimulates in vitro poly(A)
FT                                polymerase activity. Inhibits RNA
FT                                degradation activity. Inhibits the import
FT                                or stabilization of RNase P RNA into the
FT                                mitochondrial matrix. Does not inhibit
FT                                homotrimerization activity.
FT                                {ECO:0000269|PubMed:20691904}.
FT   CONFLICT    656    656       A -> V (in Ref. 2; AAK13047).
FT                                {ECO:0000305}.
FT   STRAND       46     50       {ECO:0000244|PDB:3U1K}.
FT   STRAND       52     63       {ECO:0000244|PDB:3U1K}.
FT   STRAND       67     75       {ECO:0000244|PDB:3U1K}.
FT   STRAND       78     86       {ECO:0000244|PDB:3U1K}.
FT   STRAND       92     95       {ECO:0000244|PDB:3U1K}.
FT   STRAND       98    103       {ECO:0000244|PDB:3U1K}.
FT   STRAND      105    107       {ECO:0000244|PDB:3U1K}.
FT   TURN        108    111       {ECO:0000244|PDB:3U1K}.
FT   HELIX       125    138       {ECO:0000244|PDB:3U1K}.
FT   HELIX       139    141       {ECO:0000244|PDB:3U1K}.
FT   STRAND      150    158       {ECO:0000244|PDB:3U1K}.
FT   STRAND      161    163       {ECO:0000244|PDB:3U1K}.
FT   HELIX       165    179       {ECO:0000244|PDB:3U1K}.
FT   STRAND      180    182       {ECO:0000244|PDB:3U1K}.
FT   STRAND      189    196       {ECO:0000244|PDB:3U1K}.
FT   STRAND      199    203       {ECO:0000244|PDB:3U1K}.
FT   HELIX       206    210       {ECO:0000244|PDB:3U1K}.
FT   STRAND      212    221       {ECO:0000244|PDB:3U1K}.
FT   TURN        222    224       {ECO:0000244|PDB:3U1K}.
FT   STRAND      225    236       {ECO:0000244|PDB:3U1K}.
FT   HELIX       238    266       {ECO:0000244|PDB:3U1K}.
FT   HELIX       281    299       {ECO:0000244|PDB:3U1K}.
FT   HELIX       306    327       {ECO:0000244|PDB:3U1K}.
FT   HELIX       333    355       {ECO:0000244|PDB:3U1K}.
FT   STRAND      370    374       {ECO:0000244|PDB:3U1K}.
FT   STRAND      380    388       {ECO:0000244|PDB:3U1K}.
FT   STRAND      391    400       {ECO:0000244|PDB:3U1K}.
FT   HELIX       402    405       {ECO:0000244|PDB:3U1K}.
FT   HELIX       410    416       {ECO:0000244|PDB:3U1K}.
FT   HELIX       420    422       {ECO:0000244|PDB:3U1K}.
FT   STRAND      423    428       {ECO:0000244|PDB:3U1K}.
FT   HELIX       431    434       {ECO:0000244|PDB:3U1K}.
FT   HELIX       445    458       {ECO:0000244|PDB:3U1K}.
FT   HELIX       459    461       {ECO:0000244|PDB:3U1K}.
FT   STRAND      467    478       {ECO:0000244|PDB:3U1K}.
FT   HELIX       483    497       {ECO:0000244|PDB:3U1K}.
FT   STRAND      507    517       {ECO:0000244|PDB:3U1K}.
FT   STRAND      519    522       {ECO:0000244|PDB:3U1K}.
FT   STRAND      524    532       {ECO:0000244|PDB:3U1K}.
FT   HELIX       535    539       {ECO:0000244|PDB:3U1K}.
FT   STRAND      541    549       {ECO:0000244|PDB:3U1K}.
FT   STRAND      554    561       {ECO:0000244|PDB:3U1K}.
FT   HELIX       568    592       {ECO:0000244|PDB:3U1K}.
FT   STRAND      606    611       {ECO:0000244|PDB:3U1K}.
FT   HELIX       614    621       {ECO:0000244|PDB:3U1K}.
FT   HELIX       623    625       {ECO:0000244|PDB:3U1K}.
FT   HELIX       626    635       {ECO:0000244|PDB:3U1K}.
FT   STRAND      638    641       {ECO:0000244|PDB:3U1K}.
FT   STRAND      643    653       {ECO:0000244|PDB:3U1K}.
FT   HELIX       654    663       {ECO:0000244|PDB:3U1K}.
SQ   SEQUENCE   783 AA;  85951 MW;  52DBC2119F7234E9 CRC64;
     MAACRYCCSC LRLRPLSDGP FLLPRRDRAL TQLQVRALWS SAGSRAVAVD LGNRKLEISS
     GKLARFADGS AVVQSGDTAV MVTAVSKTKP SPSQFMPLVV DYRQKAAAAG RIPTNYLRRE
     IGTSDKEILT SRIIDRSIRP LFPAGYFYDT QVLCNLLAVD GVNEPDVLAI NGASVALSLS
     DIPWNGPVGA VRIGIIDGEY VVNPTRKEMS SSTLNLVVAG APKSQIVMLE ASAENILQQD
     FCHAIKVGVK YTQQIIQGIQ QLVKETGVTK RTPQKLFTPS PEIVKYTHKL AMERLYAVFT
     DYEHDKVSRD EAVNKIRLDT EEQLKEKFPE ADPYEIIESF NVVAKEVFRS IVLNEYKRCD
     GRDLTSLRNV SCEVDMFKTL HGSALFQRGQ TQVLCTVTFD SLESGIKSDQ VITAINGIKD
     KNFMLHYEFP PYATNEIGKV TGLNRRELGH GALAEKALYP VIPRDFPFTI RVTSEVLESN
     GSSSMASACG GSLALMDSGV PISSAVAGVA IGLVTKTDPE KGEIEDYRLL TDILGIEDYN
     GDMDFKIAGT NKGITALQAD IKLPGIPIKI VMEAIQQASV AKKEILQIMN KTISKPRASR
     KENGPVVETV QVPLSKRAKF VGPGGYNLKK LQAETGVTIS QVDEETFSVF APTPSAMHEA
     RDFITEICKD DQEQQLEFGA VYTATITEIR DTGVMVKLYP NMTAVLLHNT QLDQRKIKHP
     TALGLEVGQE IQVKYFGRDP ADGRMRLSRK VLQSPATTVV RTLNDRSSIV MGEPISQSSS
     NSQ
//
